nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—Alopecia reversible—Ramipril—type 1 diabetes mellitus	0.0345	0.0691	CcSEcCtD
Alitretinoin—Red blood cell sedimentation rate increased—Ramipril—type 1 diabetes mellitus	0.0291	0.0583	CcSEcCtD
Alitretinoin—White blood cell count decreased—Ramipril—type 1 diabetes mellitus	0.0158	0.0315	CcSEcCtD
Alitretinoin—Proteinuria—Ramipril—type 1 diabetes mellitus	0.00892	0.0179	CcSEcCtD
Alitretinoin—Protein urine present—Ramipril—type 1 diabetes mellitus	0.0088	0.0176	CcSEcCtD
Alitretinoin—Drug interaction—Ramipril—type 1 diabetes mellitus	0.00845	0.0169	CcSEcCtD
Alitretinoin—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.00834	0.0167	CcSEcCtD
Alitretinoin—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00823	0.0165	CcSEcCtD
Alitretinoin—Vasculitis—Ramipril—type 1 diabetes mellitus	0.00803	0.0161	CcSEcCtD
Alitretinoin—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.00784	0.0157	CcSEcCtD
Alitretinoin—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00712	0.0143	CcSEcCtD
Alitretinoin—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.00701	0.014	CcSEcCtD
Alitretinoin—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00648	0.013	CcSEcCtD
Alitretinoin—Deafness—Ramipril—type 1 diabetes mellitus	0.00636	0.0127	CcSEcCtD
Alitretinoin—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00625	0.0125	CcSEcCtD
Alitretinoin—CRABP1—retina—type 1 diabetes mellitus	0.00617	0.143	CbGeAlD
Alitretinoin—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00616	0.0123	CcSEcCtD
Alitretinoin—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00603	0.0121	CcSEcCtD
Alitretinoin—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00598	0.012	CcSEcCtD
Alitretinoin—Arthritis—Ramipril—type 1 diabetes mellitus	0.00585	0.0117	CcSEcCtD
Alitretinoin—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00583	0.0117	CcSEcCtD
Alitretinoin—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00581	0.0116	CcSEcCtD
Alitretinoin—RXRB—islet of Langerhans—type 1 diabetes mellitus	0.00537	0.124	CbGeAlD
Alitretinoin—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00533	0.0107	CcSEcCtD
Alitretinoin—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00512	0.0103	CcSEcCtD
Alitretinoin—RXRG—Nuclear Receptor transcription pathway—VDR—type 1 diabetes mellitus	0.00506	0.0111	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP12—type 1 diabetes mellitus	0.00506	0.0111	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—DDIT3—type 1 diabetes mellitus	0.00505	0.011	CbGpPWpGaD
Alitretinoin—Gastritis—Ramipril—type 1 diabetes mellitus	0.00504	0.0101	CcSEcCtD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—ERBB3—type 1 diabetes mellitus	0.005	0.0109	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptor transcription pathway—VDR—type 1 diabetes mellitus	0.00496	0.0108	CbGpPWpGaD
Alitretinoin—Asthma—Ramipril—type 1 diabetes mellitus	0.00492	0.00984	CcSEcCtD
Alitretinoin—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00492	0.00984	CcSEcCtD
Alitretinoin—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00484	0.00968	CcSEcCtD
Alitretinoin—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00482	0.00965	CcSEcCtD
Alitretinoin—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00479	0.00959	CcSEcCtD
Alitretinoin—RARA—Nuclear Receptor transcription pathway—VDR—type 1 diabetes mellitus	0.00476	0.0104	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptor transcription pathway—VDR—type 1 diabetes mellitus	0.00476	0.0104	CbGpPWpGaD
Alitretinoin—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00471	0.00944	CcSEcCtD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—ERBB3—type 1 diabetes mellitus	0.0047	0.0103	CbGpPWpGaD
Alitretinoin—RXRA—kidney—type 1 diabetes mellitus	0.0046	0.107	CbGeAlD
Alitretinoin—Neutropenia—Ramipril—type 1 diabetes mellitus	0.0046	0.00921	CcSEcCtD
Alitretinoin—CRABP2—pancreas—type 1 diabetes mellitus	0.00459	0.106	CbGeAlD
Alitretinoin—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00457	0.00915	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00449	0.00899	CcSEcCtD
Alitretinoin—Weight increased—Ramipril—type 1 diabetes mellitus	0.00448	0.00896	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00435	0.0087	CcSEcCtD
Alitretinoin—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00432	0.00865	CcSEcCtD
Alitretinoin—Renal failure—Ramipril—type 1 diabetes mellitus	0.00431	0.00863	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.0043	0.0086	CcSEcCtD
Alitretinoin—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.0043	0.0086	CcSEcCtD
Alitretinoin—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00427	0.00856	CcSEcCtD
Alitretinoin—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00426	0.00853	CcSEcCtD
Alitretinoin—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00426	0.00853	CcSEcCtD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—VDR—type 1 diabetes mellitus	0.00425	0.00929	CbGpPWpGaD
Alitretinoin—Sweating—Ramipril—type 1 diabetes mellitus	0.0042	0.00841	CcSEcCtD
Alitretinoin—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00414	0.00828	CcSEcCtD
Alitretinoin—RXRG—cardiovascular system—type 1 diabetes mellitus	0.00413	0.0956	CbGeAlD
Alitretinoin—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00411	0.00823	CcSEcCtD
Alitretinoin—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00409	0.00819	CcSEcCtD
Alitretinoin—RARG—retina—type 1 diabetes mellitus	0.00407	0.0943	CbGeAlD
Alitretinoin—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00394	0.00788	CcSEcCtD
Alitretinoin—RXRA—Recycling of bile acids and salts—ALB—type 1 diabetes mellitus	0.00393	0.00859	CbGpPWpGaD
Alitretinoin—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00388	0.00776	CcSEcCtD
Alitretinoin—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00379	0.00759	CcSEcCtD
Alitretinoin—RXRA—Retinoic acid receptors-mediated signaling—VDR—type 1 diabetes mellitus	0.00379	0.00829	CbGpPWpGaD
Alitretinoin—RXRB—pancreas—type 1 diabetes mellitus	0.00377	0.0873	CbGeAlD
Alitretinoin—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00372	0.00745	CcSEcCtD
Alitretinoin—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00367	0.00735	CcSEcCtD
Alitretinoin—Flushing—Ramipril—type 1 diabetes mellitus	0.00365	0.00731	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.00356	0.00779	CbGpPWpGaD
Alitretinoin—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00352	0.00704	CcSEcCtD
Alitretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—type 1 diabetes mellitus	0.00351	0.00768	CbGpPWpGaD
Alitretinoin—Alopecia—Ramipril—type 1 diabetes mellitus	0.00348	0.00696	CcSEcCtD
Alitretinoin—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00345	0.0069	CcSEcCtD
Alitretinoin—Erythema—Ramipril—type 1 diabetes mellitus	0.00343	0.00686	CcSEcCtD
Alitretinoin—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00343	0.00686	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.00341	0.00747	CbGpPWpGaD
Alitretinoin—Tension—Ramipril—type 1 diabetes mellitus	0.00336	0.00673	CcSEcCtD
Alitretinoin—Nervousness—Ramipril—type 1 diabetes mellitus	0.00333	0.00666	CcSEcCtD
Alitretinoin—ABCB1—ABC-family proteins mediated transport—ABCC8—type 1 diabetes mellitus	0.00326	0.00713	CbGpPWpGaD
Alitretinoin—RXRA—PPAR Alpha Pathway—CDK4—type 1 diabetes mellitus	0.00326	0.00713	CbGpPWpGaD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—type 1 diabetes mellitus	0.00321	0.00702	CbGpPWpGaD
Alitretinoin—Tremor—Ramipril—type 1 diabetes mellitus	0.00321	0.00643	CcSEcCtD
Alitretinoin—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00318	0.00636	CcSEcCtD
Alitretinoin—RARA—kidney—type 1 diabetes mellitus	0.00317	0.0734	CbGeAlD
Alitretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—type 1 diabetes mellitus	0.00315	0.00689	CbGpPWpGaD
Alitretinoin—Agitation—Ramipril—type 1 diabetes mellitus	0.00315	0.0063	CcSEcCtD
Alitretinoin—RXRA—Nuclear Receptors—VDR—type 1 diabetes mellitus	0.00314	0.00686	CbGpPWpGaD
Alitretinoin—Malaise—Ramipril—type 1 diabetes mellitus	0.00309	0.00619	CcSEcCtD
Alitretinoin—Syncope—Ramipril—type 1 diabetes mellitus	0.00307	0.00615	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—HNF1A—type 1 diabetes mellitus	0.00305	0.00666	CbGpPWpGaD
Alitretinoin—Palpitations—Ramipril—type 1 diabetes mellitus	0.00303	0.00606	CcSEcCtD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—type 1 diabetes mellitus	0.00302	0.0066	CbGpPWpGaD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—type 1 diabetes mellitus	0.00302	0.0066	CbGpPWpGaD
Alitretinoin—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00301	0.00603	CcSEcCtD
Alitretinoin—Cough—Ramipril—type 1 diabetes mellitus	0.00299	0.00599	CcSEcCtD
Alitretinoin—Convulsion—Ramipril—type 1 diabetes mellitus	0.00297	0.00594	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—FGF21—type 1 diabetes mellitus	0.00295	0.00644	CbGpPWpGaD
Alitretinoin—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00292	0.00584	CcSEcCtD
Alitretinoin—Chest pain—Ramipril—type 1 diabetes mellitus	0.00292	0.00584	CcSEcCtD
Alitretinoin—Myalgia—Ramipril—type 1 diabetes mellitus	0.00292	0.00584	CcSEcCtD
Alitretinoin—Anxiety—Ramipril—type 1 diabetes mellitus	0.00291	0.00582	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.0029	0.0058	CcSEcCtD
Alitretinoin—Discomfort—Ramipril—type 1 diabetes mellitus	0.00288	0.00577	CcSEcCtD
Alitretinoin—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00285	0.00571	CcSEcCtD
Alitretinoin—Confusional state—Ramipril—type 1 diabetes mellitus	0.00282	0.00564	CcSEcCtD
Alitretinoin—Oedema—Ramipril—type 1 diabetes mellitus	0.0028	0.0056	CcSEcCtD
Alitretinoin—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.0028	0.0056	CcSEcCtD
Alitretinoin—Shock—Ramipril—type 1 diabetes mellitus	0.00275	0.00551	CcSEcCtD
Alitretinoin—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00274	0.00549	CcSEcCtD
Alitretinoin—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00274	0.00548	CcSEcCtD
Alitretinoin—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00273	0.00546	CcSEcCtD
Alitretinoin—RARA—lymphoid tissue—type 1 diabetes mellitus	0.00272	0.063	CbGeAlD
Alitretinoin—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00272	0.00544	CcSEcCtD
Alitretinoin—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.0027	0.00541	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.00268	0.00587	CbGpPWpGaD
Alitretinoin—Anorexia—Ramipril—type 1 diabetes mellitus	0.00267	0.00534	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP12—type 1 diabetes mellitus	0.00263	0.00576	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—DDIT3—type 1 diabetes mellitus	0.00263	0.00575	CbGpPWpGaD
Alitretinoin—Hypotension—Ramipril—type 1 diabetes mellitus	0.00261	0.00523	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.00257	0.00562	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00255	0.0051	CcSEcCtD
Alitretinoin—Insomnia—Ramipril—type 1 diabetes mellitus	0.00253	0.00506	CcSEcCtD
Alitretinoin—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00251	0.00503	CcSEcCtD
Alitretinoin—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00249	0.00499	CcSEcCtD
Alitretinoin—Somnolence—Ramipril—type 1 diabetes mellitus	0.00249	0.00498	CcSEcCtD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—VDR—type 1 diabetes mellitus	0.00248	0.00542	CbGpPWpGaD
Alitretinoin—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00246	0.00493	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—ERBB3—type 1 diabetes mellitus	0.00245	0.00536	CbGpPWpGaD
Alitretinoin—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00243	0.00487	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00241	0.00483	CcSEcCtD
Alitretinoin—Fatigue—Ramipril—type 1 diabetes mellitus	0.00241	0.00483	CcSEcCtD
Alitretinoin—Constipation—Ramipril—type 1 diabetes mellitus	0.00239	0.00479	CcSEcCtD
Alitretinoin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.00239	0.00522	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.0023	0.00461	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00229	0.00458	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—E2F1—type 1 diabetes mellitus	0.00225	0.00493	CbGpPWpGaD
Alitretinoin—Urticaria—Ramipril—type 1 diabetes mellitus	0.00222	0.00445	CcSEcCtD
Alitretinoin—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00221	0.00443	CcSEcCtD
Alitretinoin—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00221	0.00443	CcSEcCtD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—type 1 diabetes mellitus	0.00217	0.00475	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—E2F1—type 1 diabetes mellitus	0.00212	0.00463	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00206	0.00412	CcSEcCtD
Alitretinoin—RXRA—Bile acid and bile salt metabolism—ALB—type 1 diabetes mellitus	0.00205	0.00449	CbGpPWpGaD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—type 1 diabetes mellitus	0.00204	0.00447	CbGpPWpGaD
Alitretinoin—Asthenia—Ramipril—type 1 diabetes mellitus	0.00201	0.00402	CcSEcCtD
Alitretinoin—Pruritus—Ramipril—type 1 diabetes mellitus	0.00198	0.00396	CcSEcCtD
Alitretinoin—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00191	0.00383	CcSEcCtD
Alitretinoin—Dizziness—Ramipril—type 1 diabetes mellitus	0.00185	0.0037	CcSEcCtD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00185	0.00404	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00185	0.00404	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—type 1 diabetes mellitus	0.0018	0.00393	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.00178	0.00389	CbGpPWpGaD
Alitretinoin—Vomiting—Ramipril—type 1 diabetes mellitus	0.00178	0.00356	CcSEcCtD
Alitretinoin—Rash—Ramipril—type 1 diabetes mellitus	0.00176	0.00353	CcSEcCtD
Alitretinoin—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00176	0.00353	CcSEcCtD
Alitretinoin—Headache—Ramipril—type 1 diabetes mellitus	0.00175	0.00351	CcSEcCtD
Alitretinoin—CYP1A2—Melatonin metabolism and effects—ADRB1—type 1 diabetes mellitus	0.00169	0.00369	CbGpPWpGaD
Alitretinoin—Nausea—Ramipril—type 1 diabetes mellitus	0.00166	0.00333	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—INS—type 1 diabetes mellitus	0.00164	0.00358	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.00162	0.00355	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00162	0.00355	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—HBA2—type 1 diabetes mellitus	0.00162	0.00354	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—HBA2—type 1 diabetes mellitus	0.00162	0.00354	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—IGF1—type 1 diabetes mellitus	0.00158	0.00346	CbGpPWpGaD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—type 1 diabetes mellitus	0.00157	0.00344	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.00156	0.00341	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.00156	0.0034	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—type 1 diabetes mellitus	0.00155	0.00338	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—INS—type 1 diabetes mellitus	0.00154	0.00336	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—G6PC2—type 1 diabetes mellitus	0.00152	0.00333	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—G6PC2—type 1 diabetes mellitus	0.00152	0.00333	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.0015	0.00327	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—IGF1—type 1 diabetes mellitus	0.00149	0.00325	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—type 1 diabetes mellitus	0.00145	0.00318	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—type 1 diabetes mellitus	0.00145	0.00317	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—PRF1—type 1 diabetes mellitus	0.00144	0.00315	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00143	0.00313	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—CP—type 1 diabetes mellitus	0.00141	0.00309	CbGpPWpGaD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00137	0.003	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—CDK4—type 1 diabetes mellitus	0.00137	0.00299	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.00134	0.00293	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.00132	0.00289	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ABCC8—type 1 diabetes mellitus	0.00132	0.00289	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ABCC8—type 1 diabetes mellitus	0.00132	0.00289	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.00127	0.00278	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—FOXP3—type 1 diabetes mellitus	0.00127	0.00277	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PAX4—type 1 diabetes mellitus	0.00123	0.00269	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CACNA1G—type 1 diabetes mellitus	0.00123	0.00269	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—ZFP36L1—type 1 diabetes mellitus	0.0012	0.00261	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.00114	0.00249	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—E2F1—type 1 diabetes mellitus	0.0011	0.00241	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00109	0.00239	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.00109	0.00239	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—ZFP36L1—type 1 diabetes mellitus	0.00109	0.00239	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—ZFP36L1—type 1 diabetes mellitus	0.00107	0.00234	CbGpPWpGaD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—type 1 diabetes mellitus	0.00107	0.00233	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—type 1 diabetes mellitus	0.00105	0.0023	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HNF1A—type 1 diabetes mellitus	0.00105	0.00229	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PDX1—type 1 diabetes mellitus	0.00105	0.00229	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00104	0.00228	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00104	0.00228	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—ZFP36L1—type 1 diabetes mellitus	0.00103	0.00225	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—ZFP36L1—type 1 diabetes mellitus	0.00103	0.00225	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—STAT3—type 1 diabetes mellitus	0.00102	0.00224	CbGpPWpGaD
Alitretinoin—CYP1A2—Estrogen Receptor Pathway—STAT3—type 1 diabetes mellitus	0.00101	0.00221	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000984	0.00215	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—STAT3—type 1 diabetes mellitus	0.000962	0.0021	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—VDR—type 1 diabetes mellitus	0.000955	0.00209	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DPB1—type 1 diabetes mellitus	0.000921	0.00201	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-E—type 1 diabetes mellitus	0.000906	0.00198	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TNF—type 1 diabetes mellitus	0.000886	0.00194	CbGpPWpGaD
Alitretinoin—CYP1A2—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000885	0.00193	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ITPR3—type 1 diabetes mellitus	0.00088	0.00193	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ITPR3—type 1 diabetes mellitus	0.00088	0.00193	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000878	0.00192	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—VDR—type 1 diabetes mellitus	0.000874	0.00191	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CTLA4—type 1 diabetes mellitus	0.000873	0.00191	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—VDR—type 1 diabetes mellitus	0.000857	0.00187	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000853	0.00186	CbGpPWpGaD
Alitretinoin—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000851	0.0197	CbGeAlD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000842	0.00184	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TNF—type 1 diabetes mellitus	0.000833	0.00182	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—HBA1—type 1 diabetes mellitus	0.000829	0.00181	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—HBA1—type 1 diabetes mellitus	0.000829	0.00181	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—APOC3—type 1 diabetes mellitus	0.000823	0.0018	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—APOC3—type 1 diabetes mellitus	0.000823	0.0018	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—VDR—type 1 diabetes mellitus	0.000822	0.0018	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—VDR—type 1 diabetes mellitus	0.000822	0.0018	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000811	0.00177	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000809	0.00177	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000809	0.00177	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—type 1 diabetes mellitus	0.000808	0.00177	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—INS—type 1 diabetes mellitus	0.000802	0.00175	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase II conjugation—GSTT1—type 1 diabetes mellitus	0.000781	0.00171	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.00078	0.0017	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IGF1—type 1 diabetes mellitus	0.000776	0.0017	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DQA1—type 1 diabetes mellitus	0.000769	0.00168	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000745	0.00163	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000745	0.00163	CbGpPWpGaD
Alitretinoin—ABCB1—retina—type 1 diabetes mellitus	0.000727	0.0168	CbGeAlD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DQB1—type 1 diabetes mellitus	0.000719	0.00157	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—IL6—type 1 diabetes mellitus	0.000715	0.00156	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.000711	0.00156	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CD86—type 1 diabetes mellitus	0.000692	0.00151	CbGpPWpGaD
Alitretinoin—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000685	0.0159	CbGeAlD
Alitretinoin—ABCB1—Allograft Rejection—CD40LG—type 1 diabetes mellitus	0.000679	0.00148	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL10—type 1 diabetes mellitus	0.000679	0.00148	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—IL6—type 1 diabetes mellitus	0.000672	0.00147	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000671	0.00147	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.000661	0.00145	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL4—type 1 diabetes mellitus	0.000661	0.00144	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—type 1 diabetes mellitus	0.00066	0.00144	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000653	0.00143	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.000649	0.00142	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-B—type 1 diabetes mellitus	0.000646	0.00141	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GCG—type 1 diabetes mellitus	0.000644	0.00141	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GCG—type 1 diabetes mellitus	0.000644	0.00141	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000643	0.00141	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000639	0.0014	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—FASLG—type 1 diabetes mellitus	0.000631	0.00138	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IAPP—type 1 diabetes mellitus	0.000627	0.00137	CbGpPWpGaD
Alitretinoin—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000615	0.0142	CbGeAlD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000612	0.00134	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL2RA—type 1 diabetes mellitus	0.000605	0.00132	CbGpPWpGaD
Alitretinoin—ABCB1—kidney—type 1 diabetes mellitus	0.000602	0.0139	CbGeAlD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—NOS2—type 1 diabetes mellitus	0.000601	0.00131	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000601	0.00131	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-A—type 1 diabetes mellitus	0.000598	0.00131	CbGpPWpGaD
Alitretinoin—ABCB1—pancreas—type 1 diabetes mellitus	0.000598	0.0138	CbGeAlD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000596	0.0013	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.00057	0.00125	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.00056	0.00122	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DRB1—type 1 diabetes mellitus	0.000547	0.0012	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CAT—type 1 diabetes mellitus	0.000545	0.00119	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CAT—type 1 diabetes mellitus	0.000545	0.00119	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ZFP36L1—type 1 diabetes mellitus	0.000536	0.00117	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.000536	0.00117	CbGpPWpGaD
Alitretinoin—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000517	0.012	CbGeAlD
Alitretinoin—ABCB1—Allograft Rejection—CD80—type 1 diabetes mellitus	0.000505	0.0011	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—STAT3—type 1 diabetes mellitus	0.000502	0.0011	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—type 1 diabetes mellitus	0.000491	0.00107	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HBA2—type 1 diabetes mellitus	0.00049	0.00107	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PRKCQ—type 1 diabetes mellitus	0.000472	0.00103	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—G6PC2—type 1 diabetes mellitus	0.000461	0.00101	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—VDR—type 1 diabetes mellitus	0.00046	0.00101	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000457	0.000999	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000439	0.00096	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—type 1 diabetes mellitus	0.000438	0.000958	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—type 1 diabetes mellitus	0.000437	0.000955	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—TNF—type 1 diabetes mellitus	0.000434	0.000949	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—VDR—type 1 diabetes mellitus	0.000428	0.000936	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—VDR—type 1 diabetes mellitus	0.000421	0.00092	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—VDR—type 1 diabetes mellitus	0.000413	0.000902	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCC8—type 1 diabetes mellitus	0.000399	0.000873	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IFNG—type 1 diabetes mellitus	0.000399	0.000873	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—VDR—type 1 diabetes mellitus	0.000396	0.000865	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—VDR—type 1 diabetes mellitus	0.000396	0.000865	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000393	0.00086	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—INS—type 1 diabetes mellitus	0.000362	0.000792	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—INS—type 1 diabetes mellitus	0.000362	0.000792	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL1B—type 1 diabetes mellitus	0.000356	0.000779	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CASP3—type 1 diabetes mellitus	0.000355	0.000777	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL2—type 1 diabetes mellitus	0.000355	0.000776	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IL6—type 1 diabetes mellitus	0.00035	0.000766	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000341	0.000745	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000335	0.000733	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.000334	0.00073	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	0.000334	0.00073	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ALB—type 1 diabetes mellitus	0.000332	0.000726	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALB—type 1 diabetes mellitus	0.000332	0.000726	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000324	0.000709	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000319	0.000698	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.000318	0.000695	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	0.000318	0.000695	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—NOS3—type 1 diabetes mellitus	0.000318	0.000694	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—NOS3—type 1 diabetes mellitus	0.000318	0.000694	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000316	0.00069	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000312	0.000681	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CDK4—type 1 diabetes mellitus	0.000309	0.000676	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—INS—type 1 diabetes mellitus	0.000276	0.000603	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ITPR3—type 1 diabetes mellitus	0.000266	0.000583	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.000264	0.000578	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000261	0.000571	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	0.000258	0.000565	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HBA1—type 1 diabetes mellitus	0.000251	0.000548	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOC3—type 1 diabetes mellitus	0.000249	0.000545	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TYK2—type 1 diabetes mellitus	0.000246	0.000538	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTT1—type 1 diabetes mellitus	0.000245	0.000535	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.00024	0.000525	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000238	0.000521	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000228	0.000498	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000226	0.000493	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000215	0.000469	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—VDR—type 1 diabetes mellitus	0.000206	0.000451	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	0.000196	0.000428	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GCG—type 1 diabetes mellitus	0.000195	0.000427	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000184	0.000403	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000179	0.00039	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000175	0.000383	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—type 1 diabetes mellitus	0.000172	0.000377	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CAT—type 1 diabetes mellitus	0.000165	0.000361	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.00016	0.000349	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EGFR—type 1 diabetes mellitus	0.000157	0.000343	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	0.000156	0.000342	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—type 1 diabetes mellitus	0.000149	0.000326	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000147	0.000321	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000134	0.000293	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000128	0.000279	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000127	0.000279	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000126	0.000276	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—type 1 diabetes mellitus	0.00012	0.000263	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—INS—type 1 diabetes mellitus	0.00011	0.00024	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000106	0.000233	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000101	0.00022	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—type 1 diabetes mellitus	0.0001	0.00022	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	0.0001	0.000219	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	9.96e-05	0.000218	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	9.78e-05	0.000214	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NOS3—type 1 diabetes mellitus	9.61e-05	0.00021	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	8.57e-05	0.000187	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	8.5e-05	0.000186	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	8e-05	0.000175	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	7.95e-05	0.000174	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	7.81e-05	0.000171	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	7.8e-05	0.00017	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.2e-05	0.000157	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	6.6e-05	0.000144	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	6.22e-05	0.000136	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	5.27e-05	0.000115	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—INS—type 1 diabetes mellitus	4.38e-05	9.58e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	4.02e-05	8.78e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	3.84e-05	8.4e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	3.5e-05	7.65e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	3.21e-05	7.01e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	3.07e-05	6.71e-05	CbGpPWpGaD
